Prolonged hemodynamic effects (12 hours) of orally administered sustained-release nitroglycerin.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000008:administration & dosage* / Q000627:therapeutic use; D010919:Placebos; D013997:Time Factors
D003692:Delayed-Action Preparations; D010919:Placebos; D005996:Nitroglycerin